Clinical Study
Comparison of Clinical Outcomes Using “Elevate Anterior” versus “Perigee” System Devices for the Treatment of Pelvic Organ Prolapse
Table 2
Pelvic organ prolapse quantification (POP-Q) values in both groups before and 1 year after surgery. Data are given as median (range) or
[%].
| POP-Q parameters (cm) | Perigee ( = 91) | Elevate ( = 50) | values | Pre-op | Post-op | values | Pre-op | Post-op | values |
| Aa | 2 (0~3) | −2 (−1~−3) | <0.001 | 1.0 (−2~3) | −2 (−3~−1.5) | <0.001 | 0.50 | Ba | 2.5 (−1~4) | −2 (−1~−5) | <0.001 | 2.0 (−1~4) | −2 (−3~−1.5) | <0.001 | 0.19 | C | −1 (−3~5) | −6 (−5~−8) | <0.001 | −2 (−5~2) | −7.5 (−9~−6) | <0.001 | <0.01 | Ap | −1 (−2~3) | −2 (−3~0) | <0.001 | −2 (−3~0) | −2 (−3~−2)# | 0.006 | 0.22 | Bp | −1 (−2~4) | −2 (−5~0) | <0.001 | −2 (−2~1) | −2 (−3~−2) | <0.001 | 0.38 | Tvl | 8 (5~9) | 8 (6~9) | 0.54 | 8 (7~10) | 8.5 (8~10.5) | 0.90 | 0.09 | Success rate | 85 93.4 | | | 47 94 | | 1.0 |
|
|
Pre-op, preoperative; Post-op, postoperative; Tvl, total vaginal length. Wilcoxon signed rank test; Mann-Whitney test; Fisher’s exact test.
|